BPG is committed to discovery and dissemination of knowledge
JOURNAL HOME
Number of total visits
33052724
Number of visits today
7224
Number of downloads
16252035
MEMBERSHIP
BPG JOURNALS
Cited by in F6Publishing
For: Shalaby WS, Ahmed OM, Waisbourd M, Katz LJ. A Review of Potential Novel Glaucoma Therapeutic Options Independent of Intraocular Pressure. Surv Ophthalmol 2021:S0039-6257(21)00223-X. [PMID: 34890600 DOI: 10.1016/j.survophthal.2021.12.003] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Cvenkel B, Kolko M. Devices and Treatments to Address Low Adherence in Glaucoma Patients: A Narrative Review. J Clin Med 2022;12. [PMID: 36614952 DOI: 10.3390/jcm12010151] [Reference Citation Analysis]
2 Awad K, Awad R, Elkazaz H, Saleh M, Mehanna A. Applying the Health Belief Model to predict preference for surgical intervention versus medical therapy among patients with open-angle glaucoma. BMJ Open Ophth 2022;7:e001113. [DOI: 10.1136/bmjophth-2022-001113] [Reference Citation Analysis]
3 del Amo EM. Topical ophthalmic administration: Can a drug instilled onto the ocular surface exert an effect at the back of the eye? Front Drug Deliv 2022;2. [DOI: 10.3389/fddev.2022.954771] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
4 Lambuk L, Mohd Lazaldin MA, Ahmad S, Iezhitsa I, Agarwal R, Uskoković V, Mohamud R. Brain-Derived Neurotrophic Factor-Mediated Neuroprotection in Glaucoma: A Review of Current State of the Art. Front Pharmacol 2022;13:875662. [DOI: 10.3389/fphar.2022.875662] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Murtagh P, O’brien C. Corneal Hysteresis, Intraocular Pressure, and Progression of Glaucoma: Time for a “Hyst-Oric” Change in Clinical Practice? JCM 2022;11:2895. [DOI: 10.3390/jcm11102895] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Hirooka K, Kiuchi Y. The Retinal Renin-Angiotensin-Aldosterone System: Implications for Glaucoma. Antioxidants 2022;11:610. [DOI: 10.3390/antiox11040610] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
7 Löscher M, Seiz C, Hurst J, Schnichels S. Topical Drug Delivery to the Posterior Segment of the Eye. Pharmaceutics 2022;14:134. [PMID: 35057030 DOI: 10.3390/pharmaceutics14010134] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
Write to the Help Desk
© 2004-2023 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345